Your browser doesn't support javascript.
loading
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
Athale, Uma H; Puligandla, Maneka; Stevenson, Kristen E; Asselin, Barbara; Clavell, Luis A; Cole, Peter D; Kelly, Kara M; Laverdiere, Caroline; Leclerc, Jean-Marie; Michon, Bruno; Schorin, Marshall A; Sulis, Maria Luisa; Welch, Jennifer J G; Harris, Marian H; Neuberg, Donna S; Sallan, Stephen E; Silverman, Lewis B.
Afiliação
  • Athale UH; Division of Hematology/Oncology, McMaster Children's Hospital, Hamilton Health Sciences, Hamilton, ON, Canada.
  • Puligandla M; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Stevenson KE; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Asselin B; Department of Pediatrics, University of Rochester Medical Center and School of Medicine, Rochester, NY, USA.
  • Clavell LA; Department of Pediatrics, San Jorge Children's Hospital, San Juan, Puerto Rico.
  • Cole PD; Pediatrics, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Kelly KM; Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Division of Pediatric Hematology/Oncology, Jacob's School of Medicine and Biomedical Sciences, University of Buffalo, NY, USA.
  • Laverdiere C; Hematology-Oncology Division, Charles Bruneau Cancer Center, Sainte-Justine University Hospital, University of Montreal, Montreal, QC, Canada.
  • Leclerc JM; Hematology-Oncology Division, Charles Bruneau Cancer Center, Sainte-Justine University Hospital, University of Montreal, Montreal, QC, Canada.
  • Michon B; Pediatrics, Centre Hospitalier Universitaire de Quebec, Sainte-Foy, QC, Canada.
  • Schorin MA; Pediatrics, Inova Fairfax Hospital for Children, Falls Church, VA, USA.
  • Sulis ML; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Medical Center, New York, USA.
  • Welch JJG; Pediatric Hematology Oncology, Hasbro Children's Hospital/Brown University, Providence, RI, USA.
  • Harris MH; Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
  • Neuberg DS; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sallan SE; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA, USA.
Pediatr Blood Cancer ; 65(10): e27256, 2018 10.
Article em En | MEDLINE | ID: mdl-29878490
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Síndrome de Down / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Guideline Limite: Adolescent / Child / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Síndrome de Down / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Guideline Limite: Adolescent / Child / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article